Promoter Polymorphisms of the Canine SCL11A1 Gene are Correlated with Susceptibility to Canine Leishmaniosis

1Laboratory of Parasitology and Parasitic Diseases, Veterinary Faculty, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece; 22nd Department of Paediatrics, Medicine Faculty, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece; 3Diagnostic Laboratory, Department of Clinical Sciences, Veterinary Faculty, School of Health Sciences, Thessaloniki, Greece; 4Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece

[1]  M. Cancino-Diaz,et al.  NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis , 2016, BioMed research international.

[2]  M. Nilforoushzadeh,et al.  NRAMP1 gene polymorphisms and cutaneous leishmaniasis: An evaluation on host susceptibility and treatment outcome. , 2016, Journal of vector borne diseases.

[3]  M. Hida,et al.  SLC11A1 polymorphisms and susceptibility to visceral leishmaniasis in Moroccan patients. , 2014, Acta tropica.

[4]  E. Karagouni,et al.  Susceptibility and Resistance to Canine Leishmaniose is Associated to Polymorphisms of the Canine TNF-α Gene , 2011 .

[5]  A. Gajadhar,et al.  A seroepidemiological study of exposure to Toxoplasma, Leishmania, Echinococcus and Trichinella in equids in Greece and analysis of risk factors. , 2010, Veterinary parasitology.

[6]  Sandrine Caburet,et al.  Generic binding sites, generic DNA‐binding domains: where does specific promoter recognition come from? , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  K. Murphy,et al.  From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce TH1 development , 2009, Nature Immunology.

[8]  M. N. Melo,et al.  cDNA sequencing and expression of Nramp1 (Slc11a1) in dogs phenotypically resistant or susceptible to visceral leishmaniasis. , 2009, Veterinary immunology and immunopathology.

[9]  L. Ferrer,et al.  Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. , 2008, Trends in parasitology.

[10]  U. Giger,et al.  Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis. , 2008, Veterinary Research.

[11]  C. Huynh,et al.  Iron acquisition within host cells and the pathogenicity of Leishmania , 2007, Cellular microbiology.

[12]  Jacqueline K. White,et al.  Slc11a1, Formerly Nramp1, Is Expressed in Dendritic Cells and Influences Major Histocompatibility Complex Class II Expression and Antigen-Presenting Cell Function , 2007, Infection and Immunity.

[13]  S. Akira,et al.  Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.

[14]  L. Abel,et al.  Genes and environment in susceptibility to visceral leishmaniasis. , 2006, Comptes rendus biologies.

[15]  C. Barbiéri.  Immunology of canine leishmaniasis , 2006, Parasite immunology.

[16]  Armand Sánchez,et al.  Polymorphism of Slc11a1 (Nramp1) gene and canine leishmaniasis in a case-control study. , 2005, The Journal of heredity.

[17]  V. Sideris,et al.  Asymptomatic canine leishmaniasis in Greater Athens area, Greece , 1999, European Journal of Epidemiology.

[18]  Christopher Dye,et al.  Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism , 2003, Immunogenetics.

[19]  Armand Sánchez,et al.  Mapping and Sequencing of the Canine NRAMP1 Gene and Identification of Mutations in Leishmaniasis-Susceptible Dogs , 2002, Infection and Immunity.

[20]  C. Riera,et al.  The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. , 2000, Veterinary parasitology.

[21]  D. Radzioch,et al.  Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene. , 1999, Journal of immunology.

[22]  P. Gros,et al.  The Nramp1 protein and its role in resistance to infection and macrophage function. , 1999, Proceedings of the Association of American Physicians.

[23]  M. Olivier,et al.  TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.

[24]  J. Blackwell,et al.  Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility , 1999, Journal of medical genetics.

[25]  P. Gros,et al.  Macrophage NRAMP1 and its role in resistance to microbial infections , 1998, Inflammation Research.

[26]  J. Blackwell,et al.  Genetic Control of Immune Response to Recombinant Antigens Carried by an Attenuated Salmonella typhimuriumVaccine Strain: Nramp1 Influences T-Helper Subset Responses and Protection against Leishmanial Challenge , 1998, Infection and Immunity.

[27]  Y. Belkaid,et al.  The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. , 1996, Journal of immunology.

[28]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.